<< Read Full Article
<< Read Full Article
Change in Ratings
Amedisys (AMED Quote) downgraded at Deutsche Bank from Buy to Hold. $53 price target. Company could face more debt writeoffs than its peers. Estimates also cut through 2010.
AptarGroup (ATR Quote) upgraded at Merrill from Neutral to Buy. $36 price target. Company has strong secular growth prospects, even though 2009 will be a difficult year.
Bemis (BMS Quote) upgraded at Merrill from Neutral to Buy. $27 price target. Company generates more than half of its sales from food producers, and delivers steady cash flow. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |


Connect with TheStreet